サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1662074

次世代シーケンサーの世界市場

Next Generation Sequencers

出版日
ページ情報
英文 299 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
次世代シーケンサーの世界市場
出版日: 2025年02月26日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 299 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

次世代シーケンサーの世界市場は2030年までに433億米ドルに到達

2024年に166億米ドルと推定される次世代シーケンサーの世界市場は、2024年から2030年にかけてCAGR 17.3%で成長し、2030年には433億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである次世代シーケンサー消耗品は、CAGR 17.1%を記録し、分析期間終了までに266億米ドルに達すると予測されます。次世代シーケンサー・プラットフォーム分野の成長率は、分析期間中CAGR16.2%と推定されます。

米国市場は45億米ドルと推定、中国はCAGR22.8%で成長予測

米国の次世代シーケンサー市場は、2024年に45億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに100億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは22.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.0%と15.2%と予測されています。欧州では、ドイツがCAGR約13.7%で成長すると予測されています。

世界の次世代シーケンサー市場- 主要動向と促進要因のまとめ

2005年に開始された次世代シーケンシング（NGS）技術は、複数のDNA鎖の同時シーケンシングを可能にすることで、従来のサンガーシーケンシングを大きく前進させ、遺伝学の分野に革命をもたらしました。当初「超並列シーケンス」と呼ばれたこの技術は、かつてないスピードとコスト削減を実現し、広範なゲノム研究をより身近なものにしました。サンガーシーケンスはその精度の高さから、小規模なプロジェクトやNGSの結果を検証するために依然として利用されているが、NGSは効率性と拡張性に優れており、1回のランでさまざまなサンプルにわたる数百から数千の遺伝子を解析します。NGSは、一塩基変異から複雑な構造変異やRNA融合まで、幅広いゲノムの特徴を検出し、以前は不可能だった広範な遺伝子解析を容易にします。

NGSが際立つのは、その処理量の多さだけでなく、必要なサンプル量が少ないこと、精度が高いこと、希少な遺伝子変異を検出できることです。これらの特性により、医療、農業、環境科学などの多様な分野で不可欠なツールとなり、ゲノム研究、臨床診断、法医学的捜査が進展しています。NGSのプロセスは複雑で、DNAまたはcDNAサンプルを断片化し、同定しやすいようにユニークな分子アダプターに連結するシーケンスライブラリーの構築から始まる。続いて、「合成によるシーケンシング」アプローチを採用する技術を用いて、シーケンシング中のシグナル検出を強化するために、DNA断片を固体表面上でクローン増幅します。このプロセスに関与する装置は、光学的信号、あるいはIon Torrent技術のように、DNA合成中に放出される水素イオンによって生成される電気的信号によって、各ヌクレオチドの付加を検出します。データ解析の段階は複雑で、生のシーケンスデータを価値ある遺伝学的洞察に変換するための解釈の複数の段階を含みます。

さまざまな分野でNGSが幅広く応用されていることは、高スループット、スピード、コスト効率というその利点を裏付けています。臨床研究では、NGSは疾患に関連する遺伝的変異の同定に役立ち、標的治療への道を開き、遺伝子異常スクリーニングを通じて生殖医療に重要な役割を果たしています。農業分野では、植物遺伝学的研究を促進することで作物の改良を加速し、より強健な作物品種の栽培につなげています。NGSは、COVID-19パンデミックのような世界の健康上の緊急事態の際、迅速なウイルスゲノム配列決定を可能にすることで、変異の追跡やワクチン開発を支援し、特に重要な役割を果たしてきました。NGSの将来は、クラウドコンピューティングとの統合、バイオインフォマティクスの進歩、個別化医療に対する消費者の関心の高まり、学術・臨床研究の拡大、規制・倫理的枠組みの進化、戦略的提携、新興市場への投資の増加といった成長促進要因に後押しされ、個別化医療や研究開発などを強化することが期待されます。

セグメント

製品（消耗品、プラットフォーム、サービス）;エンドユーザー（学術機関・研究センター、病院・診療所、製薬・バイオテクノロジー企業、その他のエンドユーザー）

調査対象企業の例（注目の全93社）

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • Illumina Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • QIAGEN N.V.
  • RainDance Technologies Inc.
  • Roche Sequencing
  • Thermo Fischer Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6811

Global Next Generation Sequencers Market to Reach US$43.3 Billion by 2030

The global market for Next Generation Sequencers estimated at US$16.6 Billion in the year 2024, is expected to reach US$43.3 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2024-2030. Next Generation Sequencer Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the end of the analysis period. Growth in the Next Generation Sequencer Platforms segment is estimated at 16.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 22.8% CAGR

The Next Generation Sequencers market in the U.S. is estimated at US$4.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.0 Billion by the year 2030 trailing a CAGR of 22.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Next Generation Sequencers Market - Key Trends and Drivers Summarized

Next-Generation Sequencing (NGS) technologies, initiated in 2005, have revolutionized the field of genetics by allowing for the simultaneous sequencing of multiple DNA strands, a significant advancement over the traditional Sanger sequencing. This technology, originally dubbed "massively-parallel sequencing," offers unprecedented speed and reduced costs, making extensive genomic studies more accessible. While Sanger sequencing is still utilized for smaller projects or to validate NGS results due to its high accuracy, NGS excels in efficiency and scalability, analyzing hundreds to thousands of genes across various samples in a single run. NGS detects a wide range of genomic features from single nucleotide variants to complex structural variations and RNA fusions, facilitating extensive genetic analyses that were previously unfeasible.

NGS stands out not just for its volume handling but also for its lower sample requirements, higher accuracy, and the ability to detect rare genetic variants. These attributes make it an essential tool in diverse fields such as medicine, agriculture, and environmental science, advancing genomic research, clinical diagnostics, and forensic investigations. The NGS process is intricate, beginning with the construction of a sequencing library where DNA or cDNA samples are fragmented and linked to unique molecular adaptors for easy identification. This is followed by clonal amplification of the DNA fragments on a solid surface to enhance signal detection during sequencing, using technologies that employ a 'sequencing by synthesis' approach. Instruments involved in this process detect each nucleotide addition either through optical signals or, as in Ion Torrent technology, electrical signals produced by hydrogen ions released during DNA synthesis. The data analysis phase is complex, involving multiple stages of interpretation to transform raw sequencing data into valuable genetic insights.

The broad application of NGS across various sectors underscores its advantages of high throughput, speed, and cost-efficiency. In clinical research, NGS aids in identifying genetic variations associated with diseases, paving the way for targeted therapies and playing a vital role in reproductive health through genetic anomaly screenings. In agriculture, it accelerates crop improvement by facilitating plant genetic studies, leading to the cultivation of more robust crop varieties. NGS has been particularly crucial during global health emergencies, such as the COVID-19 pandemic, by enabling rapid viral genomic sequencing, which assists in tracking mutations and vaccine development. The future of NGS looks promising with ongoing advancements expected to enhance personalized medicine, agricultural development, and more, fueled by growth drivers such as integration with cloud computing, advancements in bioinformatics, rising consumer interest in personalized medicine, expanding academic and clinical research, evolving regulatory and ethical frameworks, strategic collaborations, and increased investments in emerging markets.

SCOPE OF STUDY:

The report analyzes the Next Generation Sequencers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Platforms, Services); End-Use (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 93 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • Illumina Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • QIAGEN N.V.
  • RainDance Technologies Inc.
  • Roche Sequencing
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global EconomicUpdate
    • Next Generation Sequencers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Sequencing Technologies Expand Addressable Market Opportunity
    • Increased Adoption in Clinical Diagnostics Throws the Spotlight on Sequencing Applications
    • Rising Demand for Personalized Medicine Drives Adoption of NGS
    • Integration with Artificial Intelligence and Big Data Analytics Generates New Opportunities
    • Technological Innovations in Sample Preparation and Library Construction Spur Growth
    • Growing Utilization in Oncology Research Expands Market Potential
    • Emergence of Single-Cell Sequencing Drives Adoption of Advanced NGS Technologies
    • Focus on Rare Disease Diagnostics Generates Demand for High-Throughput Sequencing
    • Development of Portable and Real-Time Sequencing Devices Expands Addressable Market
    • Rising Investments in Genomic Research Strengthens Market Demand
    • Adoption of NGS in Infectious Disease Surveillance Generates New Opportunities
    • Consumer Demand for Ancestry and Genetic Testing Drives Market Adoption
    • Integration with CRISPR and Gene Editing Technologies Generates Demand for NGS
    • Focus on Precision Medicine and Targeted Therapies Strengthens Business Case for NGS
    • Emerging Applications in Microbiome Research Propel Growth in NGS Utilization
    • Challenges in Regulatory Compliance and Quality Control
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Next Generation Sequencers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Platforms by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Next Generation Sequencers by Product - Consumables, Platforms and Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Next Generation Sequencers by Product - Consumables, Platforms and Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Next Generation Sequencers by Product - Percentage Breakdown of Value Revenues for Consumables, Platforms and Services for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Next Generation Sequencers by End-Use - Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Next Generation Sequencers by End-Use - Percentage Breakdown of Value Revenues for Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION